(0 Item)

The Synthetic Biology in Pharma Conference 2010

Business Conference - The Synthetic Biology in Pharma Conference 2010
Business Conference

By : Avakado Ltd

Date : 2010

Location : United Kingdom UK / Cambridge

PDF 272p
Description :

The conference focused on recent advances in the application of synthetic biology technologies in the fields of biopharmaceuticals and small-molecule therapeutics to identify future high-potential, high-value projects in the pharmaceutical product pipeline.

Keywords :

biopharmaceuticals compounds, biosensing, small-molecule therapeutics, xenobiologics, synthesis of DNA, molecular design

Keywords inside documents :

viral ,delphi ,genetics ,endosomal ,modeling ,escape ,lagache ,infection ,thibault ,delphigenetics ,slide ,biology ,synthetic ,plasmid ,yeast ,cells ,selection ,eyacs ,carotenoids ,production

Product/ documentation details
Engineering of lantibiotics for improved efficacy and selectivity

Product Type : Business Conference

Author : Presented by Roley Davis

PDF 17p

Languages : English

Synthetic biology applications are being developed for the design of modulated living systems. These can be specialised cells for biosensing, or highly artificial biosyntheses for high-yield production of xenobiologics, biopharmaceutical compounds, fine chemicals for use in vivo or in vitro, or biofuels.

 

Over the past few years, in a highly active technology-driven period, synthetic biology has been shaped by a small community discussing the potential of new concepts in molecular design adapted from ideas that were first developed in the fields of electronic engineering and IT.

 

It became clear that the new technologies based on synthetic genes, standardisation of functional molecular parts, synthesis of DNA (the information carrier) and software developed for ‘artificial genetic devices and systems’ had the potential to revolutionise the development of many new applications in bioproduction for many different markets.

 

Due to this potential for a new bio-based industry, carbon dioxide neutral technologies based on synthetic biology can be the key problem solvers and key drivers in the development of new applications in a clean bioindustry. However in addition, the impact of synthetic biology on the production of biopharmaceuticals and in personalised medicine is also one of the key drivers in the development of new technologies, one such example being the development of arthimisinine by US biotechnology company Amyris.

 

The Synthetic Biology in Pharma Conference organised jointly by avakado conferences and Synthetic Biology.info is the first conference designed to bring together pharmaceutical industry experts developing products for different disease indications and leading synthetic biology pioneers in order to create a forum for interchange to identify future high-potential, high-value projects in the pharmaceutical product pipeline.

 

The conference also covers applications of synthetic biology in medical development, including in drug delivery systems, recombinant antibodies and medical applications based on synthetic biology approaches.

 

The Synthetic Biology in Pharma conference therefore marks the starting point of a market-driven period for synthetic biology in pharmaceutical and medical supply applications, with the intention of establishing long-term relationships in these areas for all conference participants.

This is the original event programme. Please see the list of available presentations for purchase since not all the presentations are available for purchase.

 

 

Tuesday, March 30, 2010

Design of Artificial Pathways for the Bioproduction of Natural Compound Pharmaceuticals

 

Morning Session

 

Keynote Presentation

 

08:00-08:45
"Microbially-derived Artemisinin: Using synthetic biology to stabilise the supply of an important anti-malarial drug for the developing world"
Dr Chris Paddon, Amyris Biotechnologies

 

 

 

09:00-09:30
"Natural modularity in the service of synthetic biology"
Professor Peter Leadlay,

University of Cambridge

 

09:30-10:00
"Identification and production of complex bacterial natural products"
Professor Rolf Müller,

University of Saarbrücken

 

10:30-11:00
"Chances of synthetic biology for the generation of structural diversity in natural product biosyntheses"
Professor Roderich Süssmuth, TU Berlin

 

11:00-11:30
"Impact of biosynthetic strategies on synthetic biology"
Professor Michael Müller,
University of Freiburg

 

11:30-12:00
"Engineering of lantibiotics for improved efficacy and selectivity"
Dr Roley Davis, Novacta Biosystems Limited

 

12:00-12:30
"The quest for precursors - Metabolic fluxes in the carbon core metabolism of myxobacteria"
Dr Christoph Bolten, TU Braunschweig

 

Afternoon Session

 

13:30-14:00
"Yeast artificial chromosomes employed for random assembly of biosynthetic pathways in baker's yeast (Saccharomyces cerevisiae)"
Dr Michael Naesby, Evolva SA

 

14:00-14:30
"'ACEMBL'ing DNA for eukaryotic complexomics"
Professor Imre Berger, EMBL
Grenoble

 

14:30-15:00
"A unique coiled-coil bundle allows linking of multiple functional units"
Dr Bazbek Davletov, MRC LMB,
Cambridge

 

16:00-16:30
"Fluorescent biosensors for cell regulation pathways"
Dr Alan Waggoner,
CarnegieMellonUniversity

 

16:30-17:00
"Novel biosensors to enhanced posttranslational modification: Engineering new protein-based components by directed evolution"
Dr Dafydd Jones,
CardiffUniversity

 

17:00-18:00
Open Discussion

 

19:00-21:00
Networking Reception

 

End of Day One

 

Wednesday, March 31, 2010

On the Way to Synthetic Biology in Biomedical Applications

 

Morning Session

 

Keynote Presentation

08:00-08:45
"Synthetic biology for biomedicine"
Professor Wilfried Weber,
University of Freiburg - BIOSS

 

09:00-09:30
Dr Dagmar Wirth,
HelmholtzCenter for Infection Research - HZI

 

09:30-10:00
"The endosomal step of viral infection"
Dr Thibault Lagache, Ecole Normale Supérieure

 
10:30-11:00

"Designing long-acting analogues of glycoprotein hormones using gene fusion and gene transfer"
Professor Fuad Fares,
University of Haifa

 

11:00-11:30
"Applications in SynBio: Present and Future"
Dr Hubert Bernauer, ATG:biosynthetics GmbH

 

11:30-12:00
"A single-molecule nanoactuator: toward a device for drug discovery at the limits of sensitivity"
Dr James Youell,
University of Portsmouth

 

12:00-12:30
"Killer peptide: a novel antimicrobial, antiviral and immunomodulatory autodelivering drug"
Professor Luciano Polonelli,
University of Parma

 


13:30-14:00
"Anesthetics promote amyloid beta peptide aggregation mimicking the molecular mechanism of Alzheimer’s disease"
MD Vincenzo Fodale, School of Medicine, University of Messina

 

14:00-14:30
"Proposed new possible action of curcumin in pre-cancerous lesions: oxidative stress serum and salivary markers"
Dr Balwant Rai,
CatholicUniversity of Leuven

 

14:30-15:00
Professor Irmgart Merfort,
University of Freiburg 

 

16:00-16:30
"Use of poison and antidote genes in synthetic biology"
Dr Philippe Gabant,
Delphi Genetics

 

16:30-17:00
Open Discussion

 

End of Day Two

 

Documentation from "Synthetic Biology in Pharma " Conference

Company Description : Includes the presentations of seven speakers.

Product Type : Business Conference

Author : Various (7)

PDF 136p

Languages : English

Engineering of lantibiotics for improved efficacy and selectivity

Product Type : Business Conference

Author : Presented by Roley Davis

PDF 17p

Languages : English

Developing drugs with genetic chemistry

Product Type : Business Conference

Author : Presented by Michael Naesby

PDF 28p

Languages : English

Modeling the endosomal step of viral infection

Company Description : Slides from the speaker

Product Type : Business Conference

Author : Presented by Thibault Lagache

PDF 23p

Languages : English

Synthetic biology in pharma: present and future

Company Description : Slides from the speaker

Product Type : Business Conference

Author : Presented by Hubert Bernauer

PDF 27p

Languages : English

A single-molecule nanoactuator: toward a device for drug discovery at the limits of sensitivity

Company Description : Slides from the speaker

Product Type : Business Conference

Author : Presented by James Youell

PDF 13p

Languages : English

Proposed new possible action of curcumin in pre-cancerous lesions

Company Description : Slides for "Proposed new possible action of curcumin in pre-cancerous lesions: oxidative stress serum and salivary markers" presentation

Product Type : Business Conference

Author : Presented by Balwant Rai

PDF

Languages : English

Using poisons and antidotes in synthetic biology

Product Type : Business Conference

Author : Presented by Philippe Gabant

PDF 28p

Languages : English

Organizer : Avakado Ltd

Avakado Media is an integrated b2b media and information provider serving the pharmaceutical, biotechnology, biofuels and other life sciences industries through a range of market-leading publications,